Nebulized arformoterol, a long-acting β2-adrenergic bronchodilator, in patients with COPD.

被引：0
|
作者：
Baumgartner, Rudolf A. [1 ]
Hanrahan, John P. [1 ]
Sciarappa, Kenneth [1 ]
机构：
[1] Sepracor Inc, Marlborough, MA USA
来源：
CRITICAL CARE MEDICINE | 2006年 / 34卷 / 12期
关键词：
D O I：
10.1097/00003246-200612002-00329
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
348
引用
收藏
页码：A95 / A95
页数：1
相关论文
共 50 条
  • [21] Bronchodilator testing in patients with stable COPD.
    Herranz, AD
    ARCHIVOS DE BRONCONEUMOLOGIA, 2001, 37 (03): : 154 - 155
  • [22] FEASIBILITY, SAFETY, AND EFFICACY OF NEBULIZED LONG-ACTING BRONCHODILATORS VS NEBULIZED SHORT-ACTING BRONCHODILATORS IN HOSPITALIZED PATIENTS WITH EXACERBATIONS OF COPD
    Dhand, Rajiv
    Treat, Samuel G.
    Ferris, Jennifer
    Terry, Paul
    Walker, Tracy
    Elder, C. Scott
    Church, Daniel
    Valdes, Martin
    Dennis, Danielle
    Faircloth, Barbara
    Onar, Gulsah
    Heidel, Robert E.
    Biney, Isaac N.
    Bhagat, Milind
    Fuerst, Nicholas
    Cusick, Shannon
    CHEST, 2023, 164 (04) : 4908A - 4909A
  • [23] INDACATEROL/GLYCOPYRRONIUM VS SINGLE LONG-ACTING MUSCARINIC ANTAGONIST IN LONG-ACTING BRONCHODILATOR-NAIVE COPD PATIENTS: POOLED ANALYSIS
    Kostikas, K.
    Muro, S.
    Yoshisue, H.
    Olsson, P.
    Gupta, P.
    Wedzicha, J.
    RESPIROLOGY, 2019, 24 : 50 - 50
  • [24] Prevalence of COPD, Disease Severity, and Symptoms in Subjects on Long-Acting Bronchodilator Monotherapy for COPD
    Crater, G.
    Yawn, B.
    Bailey, W. C.
    Dransfield, M. T.
    Emmett, A.
    O'Dell, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [25] Review of the NQF Measure 0102 on Long-Acting Inhaled Bronchodilator Therapy Among COPD Patients
    Karanth, S.
    Jackson, D. D.
    Garcia, J. Barreda
    Krause, T. M.
    Cazaban, C. M. Ganduglia
    Patel, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [26] Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients
    Contoli, Marco
    Campo, Gianluca
    Pavasini, Rita
    Marchi, Irene
    Pauletti, Alessia
    Balla, Cristina
    Spanevello, Antonio
    Ferrari, Roberto
    Papi, Alberto
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 47 : 82 - 86
  • [27] Crystal habit modification and polymorphic stability assessment of a long-acting β2-adrenergic agonist
    Tulcidas, Ameessa
    Lourenco, Nuno M. T.
    Antunes, Rafael
    Santos, Bruno
    Pawlowski, Sylwin
    Rocha, Fernando
    CRYSTENGCOMM, 2019, 21 (22): : 3460 - 3470
  • [28] Age and Risks of FDA-Approved Long-Acting β2-Adrenergic Receptor Agonists
    McMahon, Ann W.
    Levenson, Mark S.
    McEvoy, Bradley W.
    Mosholder, Andrew D.
    Murphy, Dianne
    PEDIATRICS, 2011, 128 (05) : E1147 - E1154
  • [29] Methacholine Challenge as a Clinical Bioassay of Pulmonary Delivery of a Long-Acting β2-Adrenergic Agonist
    Prabhakaran, Sreekala
    Shuster, Jonathan
    Ahrens, Richard
    Hendeles, Leslie
    PHARMACOTHERAPY, 2011, 31 (05): : 449 - 457
  • [30] β2-Adrenergic receptor genetic Polymorphisms and short-term bronchodilator responses in patients with COPD
    Hizawa, Nobuyuki
    Makita, Hironi
    Nasuhara, Yasuyuki
    Betsuyaku, Tomoko
    Roh, Yoko
    Nagai, Katsura
    Hasegawa, Masant
    Nishimura, Masaham
    CHEST, 2007, 132 (05) : 1485 - 1492
12345